StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 01/27/2014 -- StockRunway.com issues special report on: Wolseley plc (ADR)(OTCMKTS:WOSYY), Softbank Corp. (Japan)(OTCMKTS:SFTBY), RXi Pharmaceuticals Corp (OTCMKTS:RXII), Akzo Nobel N.V. (ADR)(OTCMKTS:AKZOY)
Wolseley plc (ADR)(OTCMKTS:WOSYY) opened its shares at the price of $5.57 for the day. Its closing price was $5.46 after losing -3.87% for the day. The company traded with the total volume of 68,620.00 shares, while its average trading volume remained 122,774.00 shares. The beta of WOSYY stands at1.79. Wolseley plc is a specialist trade distributor of plumbing and heating products to professional contractors and a supplier of building materials in North America, the United Kingdom and Continental Europe.
Has WOSYY Found The Bottom and Ready To Move Up? Find Out Here
Softbank Corp. (Japan)(OTCMKTS:SFTBY) percentage change plunged -3.85% to close at $39.01 with the total traded volume of 282,245.00 shares, and average volume of 207,524.00 shares. The 52 week range of the stock remained $16.55 - $44.25, while its day lowest price was $39.01 and it hit its day highest price at $40.40. SoftBank Corp. operates in the information industry in Japan. It operates through four segments: Mobile Communications, Broadband Infrastructure, Fixed-line Telecommunications, and Internet Culture.
Has SFTBY Found The Bottom And Ready To Gain Momentum? Find Out Here
RXi Pharmaceuticals Corp (OTCMKTS:RXII) started its trading session with the price of $4.42 and closed at $4.25 by scoring -3.85%. RXII’s stocks traded with total volume of 103,944.00 shares, while the average trading volume remained 131,665.00 shares. Day range of the stock was $4.18 -$4.42. RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNAi platform. Its RNAi product candidate, RXI-109, is in Phase I clinical trial.
Why Should Investors Buy RXII After the Recent Fall? Just Go Here and Find Out
Akzo Nobel N.V. (ADR)(OTCMKTS:AKZOY) ended its day with the loss of -3.79% and closed at the price of $24.60 after opening at $24.93. Stock traded during its last trading session with the total volume of 248,840.00 shares, as compared to its average volume of 76,926.00 shares. Akzo Nobel NV is a manufacturer of paints, coatings and specialty chemicals based in the Netherlands. The Company operates within four segments. Within Buildings and Infrastructure segment, it manufactures decorative paints, protective, powder and coil coatings, and wood finishes for construction industry.
Will AKZOY Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)